US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 7.140
  • -0.360-4.80%
Close Feb 14 16:00 ET
  • 7.140
  • 0.0000.00%
Post 20:01 ET
152.31MMarket Cap-1.44P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Total revenue
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
Operating revenue
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
Cost of revenue
Gross profit
Operating expense
-23.42%40.5M
-12.52%189.33M
-11.01%44.46M
-24.19%42.16M
-12.97%49.82M
-1.32%52.89M
3.05%216.41M
5.48%49.96M
6.89%55.61M
8.91%57.25M
Selling and administrative expenses
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
-General and administrative expense
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
Research and development costs
-23.96%27.66M
-19.60%131.48M
-14.90%30.78M
-33.14%28.74M
-18.14%35.59M
-11.08%36.37M
-0.61%163.52M
3.94%36.17M
9.97%42.99M
3.28%43.47M
Operating profit
32.51%-23.54M
11.31%-121.69M
3.79%-29.85M
34.12%-24.19M
16.95%-32.77M
-16.24%-34.89M
-10.79%-137.21M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
Net non-operating interest income expense
-2.33%837K
-38.35%3.83M
-60.67%595K
-39.43%1.13M
-32.17%1.25M
-13.70%857K
294.91%6.21M
139.78%1.51M
375.57%1.87M
620.39%1.84M
Non-operating interest income
-34.88%2.8M
30.02%14.77M
-31.90%3.18M
-9.80%3.49M
107.35%3.81M
332.83%4.3M
622.19%11.36M
639.14%4.66M
883.72%3.87M
620.39%1.84M
Non-operating interest expense
-42.98%1.96M
112.51%10.94M
-18.09%2.58M
17.93%2.36M
--2.56M
--3.44M
--5.15M
--3.15M
--2M
--0
Other net income (expense)
73K
Gain on sale of security
----
--73K
----
----
----
----
----
----
----
----
Income before tax
33.27%-22.71M
10.08%-117.79M
1.12%-29.19M
33.84%-23.05M
16.20%-31.52M
-17.26%-34.03M
-7.21%-131M
-12.09%-29.52M
-8.39%-34.84M
-11.97%-37.61M
Income tax
33.12%-416K
-161.79%-1.74M
74.26%-363K
-109.36%-395K
-925.00%-363K
-1,729.41%-622K
751.50%2.82M
-10,171.43%-1.41M
1,044.30%4.22M
44K
Net income
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
Net income continuous Operations
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
Minority interest income
Net income attributable to the parent company
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
Basic earnings per share
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
Diluted earnings per share
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Total revenue -5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M
Operating revenue -5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M
Cost of revenue
Gross profit
Operating expense -23.42%40.5M-12.52%189.33M-11.01%44.46M-24.19%42.16M-12.97%49.82M-1.32%52.89M3.05%216.41M5.48%49.96M6.89%55.61M8.91%57.25M
Selling and administrative expenses -22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M
-General and administrative expense -22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M
Research and development costs -23.96%27.66M-19.60%131.48M-14.90%30.78M-33.14%28.74M-18.14%35.59M-11.08%36.37M-0.61%163.52M3.94%36.17M9.97%42.99M3.28%43.47M
Operating profit 32.51%-23.54M11.31%-121.69M3.79%-29.85M34.12%-24.19M16.95%-32.77M-16.24%-34.89M-10.79%-137.21M-14.72%-31.03M-12.82%-36.71M-16.56%-39.45M
Net non-operating interest income expense -2.33%837K-38.35%3.83M-60.67%595K-39.43%1.13M-32.17%1.25M-13.70%857K294.91%6.21M139.78%1.51M375.57%1.87M620.39%1.84M
Non-operating interest income -34.88%2.8M30.02%14.77M-31.90%3.18M-9.80%3.49M107.35%3.81M332.83%4.3M622.19%11.36M639.14%4.66M883.72%3.87M620.39%1.84M
Non-operating interest expense -42.98%1.96M112.51%10.94M-18.09%2.58M17.93%2.36M--2.56M--3.44M--5.15M--3.15M--2M--0
Other net income (expense) 73K
Gain on sale of security ------73K--------------------------------
Income before tax 33.27%-22.71M10.08%-117.79M1.12%-29.19M33.84%-23.05M16.20%-31.52M-17.26%-34.03M-7.21%-131M-12.09%-29.52M-8.39%-34.84M-11.97%-37.61M
Income tax 33.12%-416K-161.79%-1.74M74.26%-363K-109.36%-395K-925.00%-363K-1,729.41%-622K751.50%2.82M-10,171.43%-1.41M1,044.30%4.22M44K
Net income 33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M
Net income continuous Operations 33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M
Minority interest income
Net income attributable to the parent company 33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M
Basic earnings per share 33.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.79
Diluted earnings per share 33.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+17.56%
DexCom
DXCM
+5.92%
Hutchmed (China)
HCM
+4.39%
New Fortress Energy
NFE
+2.70%
Enerpac Tool
EPAC
+1.85%

Unlock the Full List